Last updated on November 2019

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel


Brief description of study

The purpose of this clinical study is to determine whether the addition of an oral Factor XIa Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary stroke prevention.

Clinical Study Identifier: NCT03766581

Find a site near you

Start Over

Local Institution

Dresden, Germany
7.31miles
  Connect »